UTHR insider trading — United Therapeutics Corp
Over the last 90 days, insiders at United Therapeutics Corp (UTHR) made 0 open-market purchases worth $0 and 1 open-market sale worth $115K, making them net sellers by $115K. The largest sale was by Mesa Nilda (Director), who sold 228 shares for $115K on Sep 14, 2026.
Updated Oct 16, 2026.
Recent UTHR insider transactions
Every Form 4 filed by United Therapeutics Corp officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 14, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $539.99 | $5.13M | Form 4 |
| Oct 13, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 13, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $545.52 | $5.18M | Form 4 |
| Oct 12, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 12, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $550.70 | $5.23M | Form 4 |
| Oct 9, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 9, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $544.94 | $5.18M | Form 4 |
| Oct 8, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 8, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $534.31 | $5.08M | Form 4 |
| Oct 7, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 7, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $548.95 | $5.22M | Form 4 |
| Oct 6, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 6, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $538.67 | $5.12M | Form 4 |
| Oct 5, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 5, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $541.64 | $5.15M | Form 4 |
| Oct 2, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 2, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $549.37 | $5.22M | Form 4 |
| Oct 1, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Oct 1, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $576.47 | $5.48M | Form 4 |
| Oct 1, 2026 | Mahon Paul A | EVP & GENERAL COUNSEL | M · Option exercise · 10b5-1 | Direct | 8,300 | $146.03 | $1.21M | Form 4 |
| Oct 1, 2026 | Mahon Paul A | EVP & GENERAL COUNSEL | S · Sale · 10b5-1 | Direct | 8,300 | $564.95 | $4.69M | Form 4 |
| Sep 30, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $524.48 | $4.98M | Form 4 |
| Sep 30, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 29, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 29, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $477.42 | $4.54M | Form 4 |
| Sep 28, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 28, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $480.85 | $4.57M | Form 4 |
| Sep 25, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 25, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $476.17 | $4.52M | Form 4 |
| Sep 24, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 24, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $473.55 | $4.50M | Form 4 |
| Sep 23, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 23, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $491.57 | $4.67M | Form 4 |
| Sep 22, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 22, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $494.83 | $4.70M | Form 4 |
| Sep 21, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 21, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $494.55 | $4.70M | Form 4 |
| Sep 18, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 18, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $494.79 | $4.70M | Form 4 |
| Sep 17, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 17, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $496.06 | $4.71M | Form 4 |
| Sep 17, 2026 | Mahon Paul A | EVP & GENERAL COUNSEL | M · Option exercise · 10b5-1 | Direct | 8,300 | $146.03 | $1.21M | Form 4 |
| Sep 17, 2026 | Mahon Paul A | EVP & GENERAL COUNSEL | S · Sale · 10b5-1 | Direct | 8,300 | $497.54 | $4.13M | Form 4 |
| Sep 16, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 16, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $501.39 | $4.76M | Form 4 |
| Sep 15, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 15, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $501.59 | $4.77M | Form 4 |
| Sep 14, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 14, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $504.12 | $4.79M | Form 4 |
| Sep 14, 2026 | Mesa Nilda | Director | M · Option exercise | Direct | 130 | $110.86 | $14K | Form 4 |
| Sep 14, 2026 | Mesa Nilda | Director | S · Sale | Direct | 228 | $505.87 | $115K | Form 4 |
| Sep 11, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 11, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $500.82 | $4.76M | Form 4 |
| Sep 10, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 10, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $502.35 | $4.77M | Form 4 |
| Sep 9, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 9, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $501.84 | $4.77M | Form 4 |
| Sep 8, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 8, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $499.03 | $4.74M | Form 4 |
| Sep 4, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $117.76 | $1.12M | Form 4 |
| Sep 4, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $489.20 | $4.65M | Form 4 |
| Sep 3, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $134.32 | $1.28M | Form 4 |
| Sep 3, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $487.54 | $4.63M | Form 4 |
| Sep 3, 2026 | Mahon Paul A | EVP & GENERAL COUNSEL | M · Option exercise · 10b5-1 | Direct | 8,300 | $146.03 | $1.21M | Form 4 |
| Sep 3, 2026 | Mahon Paul A | EVP & GENERAL COUNSEL | S · Sale · 10b5-1 | Direct | 8,300 | $482.03 | $4.00M | Form 4 |
| Sep 2, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $135.42 | $1.29M | Form 4 |
| Sep 2, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $493.46 | $4.69M | Form 4 |
| Sep 1, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $135.42 | $1.29M | Form 4 |
| Sep 1, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $514.09 | $4.88M | Form 4 |
| Aug 31, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $135.42 | $1.29M | Form 4 |
| Aug 31, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $511.09 | $4.86M | Form 4 |
| Aug 28, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $135.42 | $1.29M | Form 4 |
| Aug 28, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $517.51 | $4.92M | Form 4 |
| Aug 27, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $135.42 | $1.29M | Form 4 |
| Aug 27, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $522.57 | $4.96M | Form 4 |
| Aug 26, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $135.42 | $1.29M | Form 4 |
| Aug 26, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $517.28 | $4.91M | Form 4 |
| Aug 25, 2026 | Rothblatt Martine A | Chairperson & CEO | M · Option exercise · 10b5-1 | Indirect | 9,500 | $135.42 | $1.29M | Form 4 |
| Aug 25, 2026 | Rothblatt Martine A | Chairperson & CEO | S · Sale · 10b5-1 | Indirect | 9,500 | $517.71 | $4.92M | Form 4 |
Showing the 80 most recent of 138 transactions — see them all in the live tracker.
UTHR insider trading FAQ
Are insiders buying UTHR stock?
Not on the open market. In the last 90 days, United Therapeutics Corp insiders made no open-market purchases, and 1 open-market sale totaling $115K. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading UTHR?
Recent sellers: Mesa Nilda.
Where does UTHR insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.